Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of CT103A in relapsed/refractory multiple myeloma
CTR20192510Phase 2Active
- Sponsor
- Reindeer Biotech
- Start
- May 2020
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Gene Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of equecabtagene autoleucel in multiple myeloma (MM), sponsored by Reindeer Biotech. Started May 2020; status: active.
02
Drugs
equecabtagene autoleucel
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on CTR20192510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192510.